Jeff Yass’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Jeff Yass's KLRA Position: Q3 2026 in Review
Jeff Yass reduced its Kailera Therapeutics (KLRA) stake by 30% in Q3 2026, selling an estimated $168K and leaving 22,688 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11305.
Jeff Yass first reported a position in KLRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $718K in Q2 2026. 129 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Jeff Yass held 22,688 shares of Kailera Therapeutics worth $259K as of Q3 2026.
- Jeff Yass sold 9,921 Kailera Therapeutics shares in Q3 2026, an estimated $168K.
- Kailera Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11305 holding.
- Jeff Yass first reported a position in Kailera Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Jeff Yass's Kailera Therapeutics position peaked at $718K in Q2 2026.
- 129 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.